Merck & Co Inc

NYSE:MRK   3:59:59 PM EDT
81.55
+0.17 (+0.21%)
Products, Community

U.S. FDA Authorizes Merck's Covid-19 Oral Antiviral Pill

Published: 12/23/2021 14:36 GMT
Merck & Co Inc (MRK) - U.S. FDA Authorizes Merck's Covid-19 Oral Antiviral Pill.
U.S. FDA - Molnupiravir is Not Authorized for Use in Patients Younger Than 18 Years of Age Because Molnupiravir May Affect Bone and Cartilage Growth.
U.S. FDA - Molnupiravir is Administered As Four 200 Milligram Capsules Taken Orally Every 12 Hours for Five Days, for a Total of 40 Capsules.
U.S. FDA - Molnupiravir is Not Authorized for Use for Longer Than Five Consecutive Days.
Further Company Coverage: Mrkn ((reuters.
Briefs@thomsonreuters.
Com;)).